Literature DB >> 11072174

Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.

P M Ryynänen1, M Kortesniemi, J A Coderre, A Z Diaz, P Hiismäki, S E Savolainen.   

Abstract

PURPOSE: To create simple and reliable models for clinical practice for estimating the blood (10)B time-concentration curve after p-boronophenylalanine fructose complex (BPA-F) infusion in patients during neutron irradiation in boron neutron capture therapy (BNCT). METHODS AND MATERIALS: BPA-F (290 mg BPA/kg body weight) was infused i.v. during two hours to 10 glioblastoma multiforme patients. Blood samples were collected during and after the infusion. Compartmental models and bi-exponential function fit were constructed based on the (10)B blood time-concentration curve. The constructed models were tested with data from six additional patients who received various amounts of infused BPA-F and data from one patient who received a one-hour infusion of 170 mg BPA/kg body weight.
RESULTS: The resulting open two-compartment model and bi-exponential function estimate the clearance of (10)B after 290 mg BPA/kg body weight infusion from the blood with satisfactory accuracy during the first irradiation field (1 ppm, i.e., 7%). The accuracy of the two models in predicting the clearance of (10)B during the second irradiation field are for two-compartment model 1.0 ppm (8%) and 0.2 ppm (2%) for bi-exponential function. The models predict the average blood (10)B concentration with an increasing accuracy as more data points are available during the treatment.
CONCLUSION: By combining the two models, a robust and practical modeling tool is created for the estimation of the (10)B concentration in blood after BPA-F infusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072174     DOI: 10.1016/s0360-3016(00)00766-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture Reaction.

Authors:  Hitoshi Tatebe; Shin-Ichiro Masunaga; Yasumasa Nishimura
Journal:  World J Oncol       Date:  2020-08-10

2.  Structural characterization of cationic liposomes loaded with sugar-based carboranes.

Authors:  Sandra Ristori; Julian Oberdisse; Isabelle Grillo; Alessandro Donati; Olivier Spalla
Journal:  Biophys J       Date:  2004-10-15       Impact factor: 4.033

3.  Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.

Authors:  Heikki Joensuu; Leena Kankaanranta; Tiina Seppälä; Iiro Auterinen; Merja Kallio; Martti Kulvik; Juha Laakso; Jyrki Vähätalo; Mika Kortesniemi; Petri Kotiluoto; Tom Serén; Johanna Karila; Antti Brander; Eija Järviluoma; Päiivi Ryynänen; Anders Paetau; Inkeri Ruokonen; Heikki Minn; Mikko Tenhunen; Juha Jääskeläinen; Markus Färkkilä; Sauli Savolainen
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

4.  Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences.

Authors:  W S Kiger; M R Palmer; K J Riley; R G Zamenhof; P M Busse
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

5.  Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model.

Authors:  Yu-Chuan Lin; Yi-Jang Lee; Yi-Wei Chen; Shan-Ying Wang; Fong-In Chou
Journal:  Cells       Date:  2022-09-01       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.